Risks and benefits of bisphosphonate use in patients with chronic kidney disease: a population-based cohort study

First published 08/07/2015

Last updated 13/02/2019

EU PAS number:

EUPAS10029

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Risks and benefits of bisphosphonate use in patients with chronic kidney disease: a population-based cohort study

Secondary tabs

Share this page